Heparin-mediated selective release of hepatocyte growth factor in humans

British Journal of Clinical Pharmacology

Volumn 50, Issue 3, 2000, Pages 221-226

  Salbach, Peter Bernhard ^a   Brückmann, Martina ^a   Turovets, Oleg ^a   Kreuzer, Jörg ^a   Kübler, Wolfgang ^a   Walter Sack, Inge ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Healthy subjects; Hepatocyte growth factor; Low molecular weight heparin; Standard heparin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; SCATTER FACTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; ISCHEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 0033822439     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2000.00246.x     Document Type: Article

References (37)

1. Molecular cloning and expression of human hepatocyte growth factor
2. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration
3. Scatter factor induces blood vessel formation in vivo
4. Hepatocyte Growth factor is a potent angiogenic factor which stimulates endothelial cell mobility and growth
5. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor
6. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially heparectimized rats
7. A two-pronged approach to the clinical use of HGF
8. Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor
9. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure
10. Increased circulating hepatocyte growth factor in the early stages of acute myocardial infarction
11. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model
12. Site specific therapeutic angiogenesis after systemic administration of VEGF
13. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts
14. Gene therapy for myocardial angiogenesis, initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
15. Integral membrane heparane sulfate proteoglycans
16. Engineered mutants of HGF/SF with reduced binding to heparane sulphate proteoglycans, decreased clearance and enhanced activity in vivo
17. Heparin is a potent inducer of hepatocyte growth factor activity in healthy humans
18. Immediate increase in circulationg hepatocyte growth factor/scatter factor by heparin
19. Serum basic fibroblast growth factor levels in patients with ischaemic heart disease
20. Therapeutic uses if heparin beyond its traditional role as an anticoagulant
21. Low molecular weight heparins
22. Heparin modulates the receptor-binding and mitotic activity of hepatocyte growth factor on hepatocytes
23. Heparin as an inducer of HGF
24. Heparin mediated release of fibroblast growth factor-like activity into the circulation of rabbits
25. Endogenous basic fibrolblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall
26. Elevated ocular levels of vascular endothelial growth factor in paients with von Hippel-Lindau disease
27. Proteoglycans as modulators of growth factor activities
28. Collagens in the liver extracellular matrix bind hepatocyte growth factor
29. Natural hepatocyte growth factor (HGF) from human serum and a bound form of recombinant HGF with heparan sulfate are indistinguishable in their physicochemical properties
30. Angiogenic therapy of acute myocardial infarction by intrpericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study
31. Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
32. Recent insights into coronary collateral circulation
33. Comparative effect of heparin treatment with and without strenuous exercise on treadmill capacity in patients with stable effort angina
34. HGF, /SF in angiogenesis
35. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer
36. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The nordic myeloma study group
37. Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans arterial embolization of renal cell carcinoma